---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-24-000086"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2024-07-18T23:59:59+00:00"
generated_at: "2026-05-31T19:42:48.346406+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BeiGene names Aaron Rosenberg CFO effective July 22; Julia Wang resigns

## Summary
- Aaron Rosenberg appointed CFO effective July 22; Julia Wang resigns effective July 19, stays as Senior Advisor through Aug 31.
- Rosenberg receives $620k base salary, 60% target bonus, $5M equity award (mix of RSUs, options, PSUs).
- Wang receives $930k severance (18 months base) plus $559.5k for bonus/benefits; 18-month accelerated vesting of prior equity grants.
- Wang's resignation is not the result of any dispute or disagreement with BeiGene's board or management.

## SEC filing metadata
- accession: 0001651308-24-000086
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2024-07-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000086/0001651308-24-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000086/bgne-20240717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-24-000086
- JSON: https://secwatch.observer/filing/0001651308-24-000086.json
- Plain text: https://secwatch.observer/filing/0001651308-24-000086.txt

## Key facts
- Executive change
  Aaron Rosenberg was appointed as Chief Financial Officer at BeOne Medicines Ltd..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On July 18, 2024, BeiGene, Ltd. (the “Company”) announced the appointment of Aaron Rosenberg as the Chief Financial Officer (“CFO”) and the principal financial officer of the Company, effective as of July 22, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000086/0001651308-24-000086-index.htm
- Executive change
  Julia Wang resigned as Chief Financial Officer at BeOne Medicines Ltd..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On July 17, 2024, Julia Wang, the Company’s current CFO, resigned as CFO effective July 19, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000086/0001651308-24-000086-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.